Literature DB >> 32288927

Application of Best Available Technologies on Medical Wastes Disposal/Treatment in China (with case study).

Chen Jiang1, Zhiyuan Ren1, Yajing Tian1, Kaixiang Wang1.   

Abstract

Medical waste is one special kind of hazardous wastes. If mishandled, it could cause disease spread and secondary pollution of dioxin. China produced huge amount medical wastes due to large population. Through a decade, medical waste centralized disposal sector rapidly developed with both incineration and non-incineration technology. With fully consideration advanced foreign technology, a set of Best Available Technology system of China gradually formed suitable for Chinese national conditions. This article placed emphasis on best available technology system of medical wastes centralized incineration facilities, and analyzed the application of technique retrofit of medical wastes centralized incineration facilities incorporated with case study.
Copyright © 2012 Published by Elsevier B.V.

Entities:  

Keywords:  BAT/BEP; Medical Wastes; dioxins; disposal; incinerator

Year:  2012        PMID: 32288927      PMCID: PMC7129222          DOI: 10.1016/j.proenv.2012.10.036

Source DB:  PubMed          Journal:  Procedia Environ Sci        ISSN: 1878-0296


  2 in total

1.  Concentration of atmospheric pollutants in the gaseous emissions of medical waste incinerators.

Authors:  M C Ferraz; J I Cardoso; S L Pontes
Journal:  J Air Waste Manag Assoc       Date:  2000-01       Impact factor: 2.235

2.  Sustainable management measures for healthcare waste in China.

Authors:  Chen Yang; Li Peijun; Carlo Lupi; Sun Yangzhao; Xu Diandou; Feng Qian; Fu Shasha
Journal:  Waste Manag       Date:  2009-01-20       Impact factor: 7.145

  2 in total
  1 in total

1.  Assessment of medical waste generation, associated environmental impact, and management issues after the outbreak of COVID-19: A case study of the Hubei Province in China.

Authors:  Jinquan Ye; Yifan Song; Yurong Liu; Yun Zhong
Journal:  PLoS One       Date:  2022-01-24       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.